ASH 2011 Myelodysplastic Syndromes Update – Day 1 & Day 2 The MDS Beacon ATG is an antibody that also suppresses the immune system, preventing transplant rejection. The researchers found the combination was safe and associated with low rates of acute GVHD and death after transplantation. However, they also found that, even ... |
